November 16, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Edico Genome Partners with Children’s Hospital Los Angeles to Accelerate Diagnoses, Enhance Somatic and Germline Research Initiatives with DRAGEN Bio-IT Platform

SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles (CHLA). The hospital will utilize Edico Genome’s DRAGENTM Bio-IT platform to deliver enhanced patient care and accelerate research initiatives to expand test offerings for children with genetic disorders and cancer. CHLA... Read more

November 16, 2017 Clinical Research/Diagn. Product Launch

Roche launches DISCOVERY Teal HRP chromogen detection kit to advance tissue-based cancer research

    – Kit expands multiplexing options, allowing more biomarkers to be investigated on a single tissue slide – Multiplexed assays for simultaneously detecting several biomarkers in a single sample address growing need to obtain more information from limited tissue samples TUCSON, Arizona, Nov. 16, 2017 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the... Read more

November 15, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools Product Launch

QIAGEN advances precision medicine by automating guidelines on cancer variants in industry-leading QIAGEN Clinical Insight software

First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations Hilden, Germany, and Germantown, Maryland, November 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for... Read more

November 15, 2017 Clinical Research/Diagn. Informatics & Software

QIAGEN advances precision medicine by automating guidelines on cancer variants in industry-leading QIAGEN Clinical Insight software

Hilden, Germany, and Germantown, Maryland, November 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, advancing precision medicine with the first solution to offer molecular pathologists... Read more

November 15, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Illumina Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550Dx System and Expanded Use of MiSeq™Dx System

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system. The company also announced that the intended use for the MiSeq™Dx instrument has been updated to include the use of DNA libraries generated from formalin-fixed paraffin embedded (FFPE) tissues,... Read more

November 15, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools Product Launch

Fabric Genomics Announces Expanded Oncology Solution, Extending Somatic Cancer Analysis to Clinical Labs

Solution enables clinical labs that perform cancer NGS testing to quickly convert genomic insights to targeted therapies November 15, 2017 05:00 AM Pacific Standard Time SALT LAKE CITY–(BUSINESS WIRE)–This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomics will announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to... Read more

November 14, 2017 Atomic Spectroscopy Clinical Research/Diagn. Life Science Tools Microscopy

QIAGEN’s GeneReader NGS System delivers accuracy and ease of use for clinical research in oncology

Hilden, Germany, and Germantown, Maryland, November 14, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world’s first complete Sample to Insight solution for next-generation sequencing. The studies are being presented this week at the... Read more

November 14, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools PR/Corporate

Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting

Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting Thermo Fisher Scientific customers also highlight their latest research advancements in solid tumor profiling and liquid biopsy analysis during corporate workshops CARLSBAD, Calif. and SALT LAKE CITY, Nov. 14, 2017 /PRNewswire/ — Advances in next-generation sequencing (NGS)... Read more

November 13, 2017 Clinical Research/Diagn. M&A, Partnerships Mass Spectrometry

SCIEX Announces Joint Venture With Zhenjang Dian Diagnostics in China

Leading Diagnostics Companies Combine to Address Diagnostic and Wellness Testing in China November 13, 2017 04:00 AM Pacific Standard Time FRAMINGHAM, Mass. & SHANGHAI–(BUSINESS WIRE)–SCIEX Diagnostics, the in vitro diagnostics (IVD) division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today that it has formed a joint venture (JV) with Zhejiang... Read more